Physiopharmacology

Physiopharmacology

The laboratory of Physiopharmacology is affiliated with the Faculty of Medicine and Health Sciences and the Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, and represents one joint research group that bundles its expertise to focus on cardiovascular disease. 

Key publications

  • Endothelial dysfunction at the cellular level in three dimensions: severity, acuteness, and distribution. Segers et al. Am J Physiol Heart Circ Physiol. 2023; 325: H398-H413.
  • Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques. Puylaert et al. Angiogenesis. 2023; 26:505-522.
  • Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. De Meyer et al. Nat Rev Cardiol. 2024.

Research consortia

The research group Physiopharmacology is part of the Infla-Med Research Consortium of Excellence and coordinates the INSPIRE H2020 PhD project.